Session 1295: Immunotherapy

Cochair(s): J Gibbs, JW Hodge
Date: Tue 12 February 2002, Time: 14:00 - 16:00
Location: Amphithéâtre Duclaux

Oral Presentations

Time Number Title / Authors / Affiliations
14:00 539 Preclinical efficacy of dendritic cell immunotherapy for CNS tumors
AB Heimberger, LE Crotty, GE Archer, M Lendon, DD Bigner, JH Sampson
Duke University Medical Center, Durham, NC United States
14:15 540 Uptake and differential degradation of p53 mutants by dendritic cells from necrotic Saos-p53 positive cells.
M Ardle, R Germack, S Ali, RC Rees
Nottingham Trent University, Nottingham, Nottinghamshire United Kingdom
14:30 541 Tumour associated antigen ctls induced by direct intra-tumour injection of disc-hsv specifically traffic to parental tumour microcirculation in murine model
SA Ali
Department of Life Sciences, Nottingham Trent University Clifton Lane
14:45 542 Association of clinical and immunological responses to an autologous, hapten-modified human cancer vaccine.
D Berd
Thomas Jefferson University, Philadelphia, USA
15:00 543 Human immunoRNases as selective and non-immunogenic anticancer agents
G D'Alessio, C De Lorenzo, D Palmer, R Piccoli
1Dipartimento di Chimica Biologica, University of Naples Federico II, Napoli, Italy, 2Department of Immunology, Imperial College, London, U.K
15:15 544 Immunisation with a nonapeptide expressed in human tumors is able to reduce tumor growth in a rat experimental model.
S Vallebona, G Rasi, P Bernard, P Pierimarchi, FG , E Garaci
1University of Tor Vergata, Roma, Italy, 2Istitute of Neurobiology and Molecolar Medicine, Italy, 3Cancer Istitute Regina Elena, Rome, Italy
15:30 545 Exploitation of photodynamic therapy-generated immune response in cancer immunotherapy
M Korbelik
British Columbia Cancer Agency, Vancouver, Canada

Poster Presentations

Number Title / Authors / Affiliations
546 Quantitative and qualitative deficits of peripheral gd T cells in patients with active nasopharyngeal carcinoma
BJ Zheng, SP Ng, D Chua, JST Sham, D Kwong, CK Lam, MH Ng
1Department of Microbiology, 2Department of Radiation Oncology; The University of Hong Kong, Hong Kong, Peoples Republic of China, 3Hematology Section, Department of Pathology, Queen Mary Hospital, Hong Kong, Peoples Republic of China
547 A monoclonal antibody for esophageal squamous cell carcinoma and immunotargeting therapy.
T Tanaka, U Toh, T Fujii, S Sueyoshi, H Fujita, K Shirouzu, H Yamana
1Multidisciplinary treatment center, 2Department of Surgery; Kurume University School of Medicine, Kurume, Japan
548 Immunopathological study of secretory Iga expression in helicobacter pylori-infected gastric mucosa
KD Dimopoulou, E Kairi-Vassilatou, M Frangou, M Eglezou, K Kontoyanni, A Kondi-Pafiti
Areteion Hospital, Athens University Medical School-Greece, Athens, Attica Greece
549 Effects of TGFbeta on B cells of vaccinated NOD mice are dependent on costimulation via CD40: role for inhibitory Smads?
TC Martins, AP Águas
1Institute for Molecular and Cell Biology, Porto, Portugal Portugal, 2Abel Salazar Institute for the Biomedical Sciences, University of Porto, Porto, Portugal
550 The protective role of IgE in ovarian carcinoma.
SN Karagiannis, Q Wang, N East, F Burke, FR Balkwill, HJ Gould
1GKT School of Biomedical Sciences, The Randall Centre, London, United Kingdom, 2ICRF Translational Oncology Laboratory, St Bartholomew's and The Royal London School of Medicine & Dentistry, London, United Kingdom
551 *Anti-idiotypic antibodies induced by genetic immunization are directed exclusively against combined V_(L)/V_(H) determinants: implications on the mechanism of protection
F Benevenuti, M Cesco-Gaspere, OR Burrone
1Institute Curie, INSERM U520, Paris, France, 2International Centre for Genetic Engineering and Biotechnology, Trieste, Italy
552 The influence of low dose recombinant interleukin-2 (rIL-2) therapy on immunological system of patients previously treated with purine analogues.
MM Malek, A Dmoszynska, A Goracy, D Jawniak, W Legiec
Department of Haematooncology and Bone Marrow Transplantation Center, University Medical School in Lublin, Poland
553 Bcl-2 antisense oligonucleotides in the treatment neoplastic diseases in children
A Chybicka, R Chaber, J Toporski
Department of Pediatric Oncology and Hematology, Wroclaw Medical University
554 Immature and mature dendritic cells in mammary Paget's disease.
T Brunhuber, C Ensinger, G Mikuz, N Romani, S Saeland, S Lebecque, P Obrist
1Department of Pathology, 2Department of Dermatology; University of Innsbruck Medical School, Innsbruck, Austria, 3Schering-Plough Laboratory for Immunological Research, Dardilly, France
555 Immune system alterations in lung cancer patients
G Mazzoccoli, M Grilli, S Carughi, F Puzzolante, A De Cata, M La Viola, A Giuliani, R Tarquini, F Perfetto
Dept Internal Medicine Reg General Hospital Casa Sollievo Sofferenza Cappuccini Av I-71013 S Giovanni Rotondo, Italy
556 The predictive value of tumour-infiltrating lymphocytes for response to immunotherapy.
A Håkansson, B Gustafsson, L Håkansson
1Department of Oncology, Divison of Clinical Tumour Immunology, 2Department of Pathology and Cytology; University Hospital, Sweden
557 Effects of oral administration of Echinacea purpurea (American herb) and Pfaffia paniculata (Brazilian ginseng) in combination with iso-maltooligomers derived from corn starch on incidence of spontaneous leukemia in AKR/J mice
T Watanabe, T Asahi, M Watanabe, Y Watanabe, Y Yanagimoto
1Division of Res. & Develop. Mie Chemical Foods Company, Mie, Japan, 2Dept. of Human Welfare, International Buddhist University, Habikino, Osaka, Japan